These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 21401350

  • 21. [Seroconversion and immune response after anti-HBV vaccination in patients on chronic hemodialysis: comparison of two vaccines].
    Polito P, Di Lullo L, Iannacci GR, Cecilia A, Galderisi C, Gorini A.
    G Ital Nefrol; 2011; 28(5):525-30. PubMed ID: 22028266
    [Abstract] [Full Text] [Related]

  • 22. Intradermal hepatitis B vaccination in patients with advanced chronic renal failure: immunogenicity and follow-up.
    Morais EO, Resende MR, Oliveira AM, Sinkoc VM, Garcia MT, Angerami RN, da Silva LJ.
    Aliment Pharmacol Ther; 2007 Apr 01; 25(7):849-55. PubMed ID: 17373924
    [Abstract] [Full Text] [Related]

  • 23. Seroprotection after hepatitis B vaccination in chronic kidney disease patients with modified schedule and dosage.
    Siddiqui S, Malik A, Shukla I, Rizvi M, Haque SF.
    J Infect Dev Ctries; 2010 Jun 30; 4(6):389-92. PubMed ID: 20601791
    [Abstract] [Full Text] [Related]

  • 24. Clinical experience with a new recombinant hepatitis-B vaccine in previous non-responders with chronic renal insufficiency.
    Haubitz M, Ehlerding G, Beigel A, Heuer U, Hemmerling AE, Thoma HA.
    Clin Nephrol; 1996 Mar 30; 45(3):180-2. PubMed ID: 8706359
    [Abstract] [Full Text] [Related]

  • 25. Response to the hepatitis B virus vaccine in haemodialysis patients: influence of malnutrition and its importance as a risk factor for morbidity and mortality.
    Fernández E, Betriu MA, Gómez R, Montoliu J.
    Nephrol Dial Transplant; 1996 Aug 30; 11(8):1559-63. PubMed ID: 8856211
    [Abstract] [Full Text] [Related]

  • 26. The effect of high dose and short interval HBV vaccination in individuals with chronic hepatitis C.
    Idilman R, De MN, Colantoni A, Nadir A, Van Thiel DH.
    Am J Gastroenterol; 2002 Feb 30; 97(2):435-9. PubMed ID: 11866284
    [Abstract] [Full Text] [Related]

  • 27. Impaired antibody response rates after high dose short interval hepatitis B virus vaccination of immunosuppressed individuals.
    Idilman R, Colantoni A, De Maria N, Ustun C, Sam R, Ing TS, Akan H, Koc H, Van Thiel DH.
    Hepatogastroenterology; 2003 Feb 30; 50(49):217-21. PubMed ID: 12630026
    [Abstract] [Full Text] [Related]

  • 28. Hepatitis B surface antigenemia following recombinant Engerix B hepatitis B vaccine in an 81-year-old ESRD patient on hemodialysis.
    Onuigbo MA, Nesbit A, Weisenbeck J, Hurlburt J.
    Ren Fail; 2010 May 30; 32(4):531-2. PubMed ID: 20446799
    [Abstract] [Full Text] [Related]

  • 29. Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C.
    Wiedmann M, Liebert UG, Oesen U, Porst H, Wiese M, Schroeder S, Halm U, Mössner J, Berr F.
    Hepatology; 2000 Jan 30; 31(1):230-4. PubMed ID: 10613751
    [Abstract] [Full Text] [Related]

  • 30. Efficacy of a hepatitis B vaccination schedule with two cycles of four double doses of conventional vaccine and four doses of adjuvanted vaccine in chronic kidney disease patients evaluated for renal transplantation.
    García-Agudo R, Aoufi Rabih S, Araque Torres P, Dolores Fraga Fuentes M, Carlos Valenzuela Gámez J, Mancha Ramos J, María Tenías Burillo J.
    Transplant Proc; 2012 Nov 30; 44(9):2532-4. PubMed ID: 23146445
    [Abstract] [Full Text] [Related]

  • 31. A randomised controlled trial of intradermal hepatitis B vaccination and augmentation of response with erythropoietin.
    Anandh U, Thomas PP, Shastry JC, Jacob CK.
    J Assoc Physicians India; 2000 Nov 30; 48(11):1061-3. PubMed ID: 11310381
    [Abstract] [Full Text] [Related]

  • 32. Effects of oral levamisole as an adjuvant to hepatitis B vaccine in adults with end-stage renal disease: a meta-analysis of controlled clinical trials.
    Alavian SM, Tabatabaei SV.
    Clin Ther; 2010 Jan 30; 32(1):1-10. PubMed ID: 20171406
    [Abstract] [Full Text] [Related]

  • 33. [New vaccination protocol against hepatitis B for hemodialysis patients--a single-centre experience].
    Resić H, Kukavica N, Masnić F, Prohić N, Sahović V, Ajanović S, Corić A, Avdić E, Helać-Cvijetić D.
    Acta Med Croatica; 2011 Dec 30; 65(5):405-14. PubMed ID: 22994011
    [Abstract] [Full Text] [Related]

  • 34. Persistence of hepatitis B vaccine immunity in hemodialysis patients.
    Ramezani A, Velayati AA, Eslamifar A, Banifazl M, Ahmadi F, Maziar S, Razeghi E, Kalantar E, Amirkhani A, Aghakhani A.
    Ther Apher Dial; 2008 Apr 30; 12(2):143-6. PubMed ID: 18387163
    [Abstract] [Full Text] [Related]

  • 35. The evaluation of the effectiveness of multiple dose intradermal hepatitis B re-vaccination in hemodialyzed patients not responding to standard method of immunization.
    Radziszewski A, Gajda M, Pituch-Noworolska A, Drozdz M, Kraśniak A, Kaczmarczyk I, Hołyś S, Zurowski J, Sydor A, Sułowicz W.
    Przegl Lek; 2007 Apr 30; 64(7-8):470-5. PubMed ID: 18409347
    [Abstract] [Full Text] [Related]

  • 36. Hepatitis B virus vaccine in lymphoproliferative disorders: a prospective randomized study evaluating the efficacy of granulocyte-macrophage colony stimulating factor as a vaccine adjuvant.
    Yağci M, Acar K, Sucak GT, Yamaç K, Haznedar R.
    Eur J Haematol; 2007 Oct 30; 79(4):292-6. PubMed ID: 17655695
    [Abstract] [Full Text] [Related]

  • 37. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
    Bialek SR, Bower WA, Novak R, Helgenberger L, Auerbach SB, Williams IT, Bell BP.
    Pediatr Infect Dis J; 2008 Oct 30; 27(10):881-5. PubMed ID: 18756185
    [Abstract] [Full Text] [Related]

  • 38. Primary high-dose intradermal hepatitis B vaccination in hemodialysis: cost-effectiveness evaluation at 2 years.
    Mat O, Mestrez F, Beauwens R, Muniz-Martinez MC, Dhaene M.
    Hemodial Int; 2006 Jan 30; 10(1):49-55. PubMed ID: 16441827
    [Abstract] [Full Text] [Related]

  • 39. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
    Kallinowski B, Jilg W, Buchholz L, Stremmel W, Engler S.
    Z Gastroenterol; 2003 Oct 30; 41(10):983-90. PubMed ID: 14562195
    [Abstract] [Full Text] [Related]

  • 40. Efficacy of repeated high-dose hepatitis B vaccine (80 microg) in patients with chronic liver disease.
    Aziz A, Aziz S, Li DS, Murphy L, Leone N, Kennedy M, Dhillon S, Van Thiel DH.
    J Viral Hepat; 2006 Apr 30; 13(4):217-21. PubMed ID: 16611186
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.